Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

NCT04504396 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

620

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: GLP-1 receptor agonist
DRUG: Placebo

Sponsor

PegBio Co., Ltd.